D. Beitner-Johnson

Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element.

H. Werner, D. Beitner-Johnson, C. Roberts, 1995, Molecular endocrinology.

The molecular basis of O2-sensing and hypoxia tolerance in pheochromocytoma cells.

D. Beitner-Johnson, Y. Yuan, L. Conforti, 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

Biochemical adaptations in the mesolimbic dopamine system in response to heroin self‐administration

E. Nestler, D. Beitner-Johnson, D. Self, 1995, Synapse.

Sphingosine 1-Phosphate Stimulates Tyrosine Phosphorylation of Crk*

S. Spiegel, D. Beitner-Johnson, D. Leroith, 1997, The Journal of Biological Chemistry.

The proto-oncogene Crk-II enhances apoptosis by a Ras-dependent, Raf-1/MAP kinase-independent pathway.

D. Beitner-Johnson, D. Le Roith, M. Párrizas, 1997, Biochemical and biophysical research communications.

Glial Fibrillary Acidic Protein and the Mesolimbic Dopamine System: Regulation by Chronic Morphine and Lewis‐Fischer Strain Differences in the Rat Ventral Tegmental Area

E. Nestler, D. Beitner-Johnson, X. Guitart, 1993, Journal of neurochemistry.

Dopaminergic brain reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine- and cocaine-regulated phosphoproteins

E. Nestler, D. Beitner-Johnson, X. Guitart, 1991, Brain Research.

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

J. Oliveira, C. Wanner, D. Beitner-Johnson, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.